Clinical Trial

Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated February 16, 2023 (before its estimated March 2024 completion). Its status may not reflect the trial's current state.
Summary
This is a randomized, double-blinded, placebo-controlled, crossover trial that aims to 1) determine the efficacy of THC-free cannabidiol (CBD oil) in reducing the severity of agitation among participants and 2) determine whether THC-free CBD oil can reduce the burden on caregivers and increase the participants' quality of life.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2020-06-16; most recent amendment 2026-04-12.
Status change: Recruiting → Completed 2026-04-12
Status change: Not Yet Recruiting → Recruiting 2021-03-23
Trial Details
NCT Number NCT04436081
Lead Sponsor Eastern Virginia Medical School
Collaborators: Old Dominion University, Ananda Hemp, Inc.
Conditions Alzheimer Disease, Dementia, Major Neurocognitive Disorder With Aggressive Behavior
Enrollment 40 participants
Start Date 2021-02-26
Primary Completion 2024-03 (estimated)
Study Completion 2024-03 (estimated)
Updated on ClinicalTrials.gov 2023-02-16